Monitoring protoporphyrin IX accumulation in oral cancer patients demonstrates potential for enhancing photodynamic therapy dosimetry.
Overall, the results show that imaging of PP accumulation is feasible by adapting traditional photodiagnosis optical components and may serve as a dosimetry reporter for ALA-PDT, which is complementary to the measurement of PpIX photobleaching.
No takes yet. Share an insight, caveat, or question.
Liboy et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: